Loading clinical trials...
Loading clinical trials...
A Long-term, Open Label, Safety and Tolerability Study of Cannabis Based Medicine Extract in Patients Who Have Participated in a GW Clinical Study Using Cannabis Based Medicine.
Conditions
Interventions
GW-1000-02
Locations
1
United Kingdom
Gartnavel General Hospital
Glasgow, United Kingdom
Start Date
February 1, 2002
Primary Completion Date
December 1, 2004
Completion Date
December 1, 2004
Last Updated
May 6, 2023
NCT06276634
NCT07225504
NCT06346132
NCT07482709
NCT07351968
NCT06946290
Lead Sponsor
Jazz Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions